Joshi v. The Trustees of Columbia University in the City of New York

Background

Dr. Shailendra Joshi, an anesthesiologist at Columbia University College of Physicians and Surgeons, sued the Trustees of Columbia University, Columbia University in the City of New York, and Columbia University College of Physicians and Surgeons. He alleged that the defendants retaliated against him, or failed to protect him from retaliation, after he reported suspected research misconduct involving the Division Chief.

After an earlier ruling on a motion to dismiss, four claims remained: breach of contract; breach of the implied duty of good faith and fair dealing; promissory estoppel, which can enforce a promise when reasonable reliance causes injury; and violation of Section 715-b of the New York Not-for-Profit Corporation Law.

Dr. Joshi first raised data concerns in December 2014 and sent a research-misconduct letter to the University’s Vice President for Research Compliance, Training, and Policy on April 3, 2015. The University later conducted formal inquiries. An Ad Hoc Committee found that the Division Chief had recklessly overstated the completeness of data, but the Standing Committee concluded that research misconduct had not been established. Dr. Joshi later complained that he was being retaliated against through employment decisions and other actions.

Summary-Judgment Standard

The defendants sought summary judgment under Federal Rule of Civil Procedure 56. Summary judgment is appropriate when the evidence shows no genuine dispute about a fact that could affect the result and the moving party is entitled to judgment under the law. The court must draw reasonable inferences for the nonmoving party, but that party must identify evidence supporting a genuine factual dispute.

Breach of Contract

Dr. Joshi argued that Columbia’s Research Misconduct Policy and Non-Retaliation Policy were enforceable employment contracts. The court held that disputed facts prevented summary judgment on whether the policies could be contractual, including which versions Dr. Joshi relied on and whether applicable disclaimers were sufficiently clear. The court also concluded that the record did not establish that the defendants breached the policies.

The alleged retaliatory actions included failing to promote Dr. Joshi to Full Professor, failing to select him as Division Chief, denying a joint appointment with Neurosurgery, increasing his clinical and electroconvulsive-therapy duties, threatening to close his lab, and damaging his reputation.

The court concluded that the evidence did not support retaliation. The promotion delays began before Dr. Joshi’s research-misconduct report, and he had repeatedly declined or failed to complete the promotion process under the former chair. After the report, Dr. Brambrink supported Dr. Joshi’s promotion to Associate Professor, which became effective July 1, 2018. The court found no evidence that the decision not to give him an unusual two-step promotion was retaliatory.

The court also found that Dr. Brambrink used non-retaliatory criteria for selecting a new Division Chief: choosing someone from outside the University who would bring new external research funding. Dr. Joshi did not meet those criteria, and Dr. Paul Garcia was selected. The court found no evidence that the criteria were a pretext for retaliation.

The court reached a similar conclusion about the proposed joint appointment with Neurosurgery. Dr. Solomon was unaware of Dr. Joshi’s research-misconduct allegation when he rejected the possibility, and Dr. Joshi did not meet with Dr. Wood to advance the process. The court also found that the reduction in non-clinical time reflected Dr. Joshi’s loss of external grant funding, and that the request that he resume electroconvulsive-therapy duties occurred before the court’s identified protected activity and during a staffing shortage. The court further noted that those duties were part of the responsibilities of physicians in the Neuroanesthesiology Division.

Regarding the lab, the court found that Columbia continued providing bridge funding after Dr. Joshi’s external funding ended and kept the lab open for years. The court concluded that the plan to close the lab if Dr. Joshi did not obtain outside funding was based on funding concerns, not retaliation. Finally, the court held that Dr. Joshi had not identified specific lost business opportunities needed to recover contract damages for reputational harm, and the evidence did not show that the defendants damaged his reputation because of his report.

Good Faith and Fair Dealing

The court held that disputed facts about whether the policies were contracts prevented summary judgment on that issue alone. But the undisputed evidence showed that the defendants did not breach the implied duty of good faith and fair dealing. The University investigated Dr. Joshi’s retaliation complaints, reviewed his clinical assignments, funding, salary, and proposed joint appointment, and had its Office of General Counsel complete the investigation.

The court also rejected Dr. Joshi’s argument that the research-misconduct investigation violated required deadlines. The policy provided estimated timelines and allowed reasonable extensions. The court found that the extensions were authorized and that Dr. Joshi identified no evidence of bad faith or cognizable injury caused by the length of the investigation.

Promissory Estoppel

The court held that Dr. Joshi’s promissory-estoppel claim was duplicative of his contract claim because he relied on the same alleged promises in arguing that the policies formed contracts. Independently, the claim failed because he did not show injury caused by a promise. The Department kept his lab open, provided funding and non-clinical time beyond what it was required to provide, and Dr. Joshi had no entitlement to the promotions he sought.

New York Whistleblower Statute

The court had previously found persuasive authority supporting a private right of action under Section 715-b, which requires certain nonprofit corporations to adopt and oversee a policy protecting people who report suspected improper conduct. Even so, the court granted summary judgment because the undisputed evidence showed that Columbia adopted the required policies, implemented them, investigated Dr. Joshi’s reports, offered protection from retaliation, and had board oversight through periodic compliance reporting. Dr. Joshi identified no evidence that Columbia failed to comply with the statute.

Disposition

The court granted the defendants’ motion for summary judgment. The Clerk was directed to enter judgment dismissing the case with prejudice, close all pending motions, and close the case.